IGF2BP2 and leukemia: Consistently, the mice bearing IGF2BP2-deficient cells manifested ameliorated splenomegaly, more reddish bones (Fig. 5B), and suppressed leukemia cell dissemination in the bone marrow and spleen (Supplementary Fig. 8C).